Blood Testing
September 19, 2024
Regular blood testing for those with CLL and SLL is an important part of managing the disease, as it can provide valuable insights into your overall health.
Regular blood testing for those with CLL and SLL is an important part of managing the disease, as it can provide valuable insights into your overall health.
Regular blood testing for those with CLL and SLL is an important part of managing the disease, as it can provide valuable insights into your overall health.
MRD-guided ibrutinib-venetoclax significantly improved outcomes for previously untreated patients with CLL compared with ibrutinib or chemoimmunotherapy.
March 2025 CLL Bloodline: The CLL Society Bloodline will teach the BASICS needed to understand CLL.
February 2025 CLL Bloodline: The CLL Society Bloodline will teach the BASICS needed to understand CLL.
BeiGene and CLL Society partnered on Test Before Treat, educating healthcare providers and CLL / SLL patients about the importance of biomarker testing.
It’s been a month since my last post on progress in my trial of epcoritamab, a bispecific T cell engager (BiTE) for my chronic lymphocytic leukemia.
Measurable residual disease (MRD) testing measures the amount of cancer cells that are present in blood or bone marrow at the time the sample was collected.
I found out last week that I am not only in a complete remission, but also there was no measurable CLL in my peripheral blood done by flow cytometry, down to 1 in 10,000 cells